Precision Medicine in Oncology

The emerging precision medicine approach aims to tailor disease prevention and treatment to each patient on the basis of individual variability, environmental factors and lifestyle. Fundamental achievements in the last few decades have converged to offer nowadays the compelling opportunity to move t...

Full description

Saved in:
Bibliographic Details
Superior document:Frontiers Research Topics
:
Year of Publication:2019
Language:English
Series:Frontiers Research Topics
Physical Description:1 electronic resource (163 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993548697104498
ctrlnum (CKB)4920000000094081
(oapen)https://directory.doabooks.org/handle/20.500.12854/56871
(EXLCZ)994920000000094081
collection bib_alma
record_format marc
spelling Andrea Lunardi auth
Precision Medicine in Oncology
Frontiers Media SA 2019
1 electronic resource (163 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Frontiers Research Topics
The emerging precision medicine approach aims to tailor disease prevention and treatment to each patient on the basis of individual variability, environmental factors and lifestyle. Fundamental achievements in the last few decades have converged to offer nowadays the compelling opportunity to move towards this innovative approach: i) unprecedented improvements in disease modeling in silico, in vitro and in vivo; ii) acquisition of a wide range of biomedical information combined with the development of computational toolsets for flexible and integrative analyses of multi-assay datasets. Our deeper understanding of oncogenic mechanisms has finally begun to have a crucial impact on clinical decisions at several steps, from cancer prevention and diagnosis to therapeutic intervention. However, precision oncology still encounters several unresolved hurdles including tumour heterogeneity and recurrence as well as unexplained drug resistance and lack of effective ways to monitor response to therapeutic treatments. Notably, limitations in biomedical research regulation and governance represent additional debatable issues that need careful consideration.
English
computational biology
synthetic biology
pathology
noncoding RNA
aberration
precision medicine
in vivo preclinical platform
oncology
2-88945-705-2
Angela Re auth
Caterina Nardella auth
Alessandro Quattrone auth
language English
format eBook
author Andrea Lunardi
spellingShingle Andrea Lunardi
Precision Medicine in Oncology
Frontiers Research Topics
author_facet Andrea Lunardi
Angela Re
Caterina Nardella
Alessandro Quattrone
author_variant a l al
author2 Angela Re
Caterina Nardella
Alessandro Quattrone
author2_variant a r ar
c n cn
a q aq
author_sort Andrea Lunardi
title Precision Medicine in Oncology
title_full Precision Medicine in Oncology
title_fullStr Precision Medicine in Oncology
title_full_unstemmed Precision Medicine in Oncology
title_auth Precision Medicine in Oncology
title_new Precision Medicine in Oncology
title_sort precision medicine in oncology
series Frontiers Research Topics
series2 Frontiers Research Topics
publisher Frontiers Media SA
publishDate 2019
physical 1 electronic resource (163 p.)
isbn 2-88945-705-2
illustrated Not Illustrated
work_keys_str_mv AT andrealunardi precisionmedicineinoncology
AT angelare precisionmedicineinoncology
AT caterinanardella precisionmedicineinoncology
AT alessandroquattrone precisionmedicineinoncology
status_str n
ids_txt_mv (CKB)4920000000094081
(oapen)https://directory.doabooks.org/handle/20.500.12854/56871
(EXLCZ)994920000000094081
carrierType_str_mv cr
hierarchy_parent_title Frontiers Research Topics
is_hierarchy_title Precision Medicine in Oncology
container_title Frontiers Research Topics
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
_version_ 1787551938732097536
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02302nam-a2200397z--4500</leader><controlfield tag="001">993548697104498</controlfield><controlfield tag="005">20231214133315.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2019 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000094081</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/56871</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000094081</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Andrea Lunardi</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Precision Medicine in Oncology</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (163 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The emerging precision medicine approach aims to tailor disease prevention and treatment to each patient on the basis of individual variability, environmental factors and lifestyle. Fundamental achievements in the last few decades have converged to offer nowadays the compelling opportunity to move towards this innovative approach: i) unprecedented improvements in disease modeling in silico, in vitro and in vivo; ii) acquisition of a wide range of biomedical information combined with the development of computational toolsets for flexible and integrative analyses of multi-assay datasets. Our deeper understanding of oncogenic mechanisms has finally begun to have a crucial impact on clinical decisions at several steps, from cancer prevention and diagnosis to therapeutic intervention. However, precision oncology still encounters several unresolved hurdles including tumour heterogeneity and recurrence as well as unexplained drug resistance and lack of effective ways to monitor response to therapeutic treatments. Notably, limitations in biomedical research regulation and governance represent additional debatable issues that need careful consideration.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">computational biology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">synthetic biology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pathology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">noncoding RNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aberration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">precision medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vivo preclinical platform</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oncology</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88945-705-2</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Angela Re</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Caterina Nardella</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alessandro Quattrone</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:49:56 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338851680004498&amp;Force_direct=true</subfield><subfield code="Z">5338851680004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338851680004498</subfield></datafield></record></collection>